Experimental Drug Reverses Fatty Liver Disease by Targeting the Gut-Liver Axis
In a significant development for the treatment of metabolic disorders, researchers at Michigan Medicine have identified a promising new strategy for managing metabolic dysfunction-associated steatohepatitis (MASH), a severe form of…
